CORRECTION article

Front. Immunol., 06 December 2023

Sec. Molecular Innate Immunity

Volume 14 - 2023 | https://doi.org/10.3389/fimmu.2023.1345777

Corrigendum: MSC therapy ameliorates experimental gouty arthritis hinting an early COX-2 induction

  • 1. Bone and Joint Research Unit, Rheumatology Dept, IIS-Fundación Jiménez Díaz Universidad Autonoma de Madrid (UAM), Madrid, Spain

  • 2. Hematopoietic Innovative Therapies Division, Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas (CIEMAT) and Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBER-ER), Madrid, Spain

  • 3. Advanced Therapies Dept, IIS-Fundación Jiménez Díaz UAM, Madrid, Spain

  • 4. New Therapies Laboratory, IIS-Fundación Jiménez Díaz UAM, Madrid, Spain

  • 5. Department of Surgery, Fundación Jiménez Díaz University Hospital, Madrid, Spain

  • 6. Department of Surgery, School of Medicine UAM, Madrid, Spain

In the published article, there was an error in the Funding statement. The funding statement was displayed as “This study was supported by research grants from the Instituto de Salud Carlos III (PIE15/00048; PI15/00770; PI18/00261; PI20/00349; PI22/00352), co-funded by Fondo Europeo de Desarrollo Regional (FEDER).” The correct statement is “This study was supported by research grants from the Instituto de Salud Carlos III (PIE15/00048; PI15/00770; PI18/00261; PI20/00349; PI22/00352), co-funded by the European Union.”

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Statements

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Summary

Keywords

mesenchymal stem cells (MSCs), innate inflammation, macrophage, polarization, inflammasome, prostaglandin E2, COX-2

Citation

Medina JP, Bermejo-Álvarez I, Pérez-Baos S, Yáñez R, Fernández-García M, García-Olmo D, Mediero A, Herrero-Beaumont G and Largo R (2023) Corrigendum: MSC therapy ameliorates experimental gouty arthritis hinting an early COX-2 induction. Front. Immunol. 14:1345777. doi: 10.3389/fimmu.2023.1345777

Received

28 November 2023

Accepted

29 November 2023

Published

06 December 2023

Approved by

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Volume

14 - 2023

Updates

Copyright

*Correspondence: Gabriel Herrero-Beaumont,

†These authors have contributed equally to this work and share first authorship

Disclaimer

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Outline

Cite article

Copy to clipboard


Export citation file


Share article

Article metrics